Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Facultad Nacional de Salud Pública
Print version ISSN 0120-386XOn-line version ISSN 2256-3334
Abstract
CARDONA-ARIAS, Jaiberth Antonio and ORREGO-MARIN, Claudia Patricia. Meta-analysis of the diagnostic validity of Human Immunodeficiency Virus screening tests in blood banks, 2000-2020. Rev. Fac. Nac. Salud Pública [online]. 2022, vol.40, n.3, e04. Epub May 31, 2023. ISSN 0120-386X. https://doi.org/10.17533/udea.rfnsp.e347170.
Objective:
To evaluate the diagnostic validity of the enzyme-linked immunosorbent assay (ELISA) for human immunodeficiency virus (HIV) in blood banks, based on studies published between 2000 and 2020.
Methodology:
We performed a systematic review and meta-analysis of diagnostic tests, using a random-effects model for the sensitivity, specificity, positive and negative likelihood ratio, diagnostic odds ratio (DOR), and ROC curve, with 95% confidence intervals. Heterogeneity was assessed with the DerSimonianLaird Q(χ2) statistic and the I2 inconsistency statistic. Uncertainty was assessed using percentage study weights.
Results:
15 studies were included. The third-generation ELISA (antibody detection) was applied for 2,992 infected and 4,076 healthy individuals, and the fourth-generation ELISA (simultaneous antigen-antibody detection) was used for 967 infected and 154,264 healthy individuals. Both showed close to 100% sensitivity, but there was an improved specificity in the fourth-generation assays (98% vs. 100%). Both technologies’ likelihood ratios, DOR, and ROC curve aptly distinguished between healthy and infected individuals.
Conclusion:
The third and fourth-generation ELISA were confirmed to have excellent validity and diagnostic utility in blood donors, which is important for HIV control and blood safety policies.
Keywords : blood bank; enzyme-linked immunosorbent assay (ELISA); meta-analysis; diagnostic validity; human immunodeficiency virus (HIV).